High expression of SLC27A2 predicts unfavorable prognosis and promotes inhibitory immune infiltration in acute lymphoblastic leukemia
2024 · Translational Oncology · 5 citations
https://doi.org/10.1016/j.tranon.2024.101952
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
28
Citations
3
h-index
0
i10-index
Luting Luo is an academic researcher from Fujian Medical University. The author has contributed to research in topics: Acute Lymphoblastic Leukemia research & Epigenetics and DNA Methylation & Lymphoma Diagnosis and Treatment. The author has an h-index of 3, co-authored 15 publications.
ORCID: 0000-0003-1406-2168https://doi.org/10.1016/j.tranon.2024.101952
https://doi.org/10.1016/j.isci.2025.113752
Click to start Chat